{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:17:43Z","timestamp":1793053063161,"version":"4.5.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Traumatic brain injury (TBI) is a leading cause of death and disability globally and is associated with long-term cognitive and neurobehavioural deficits. Methylphenidate has been proposed to address these lasting symptoms, however comprehensive evidence is lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This systematic review aimed to assess the effects of methylphenidate on multiple cognitive and neurobehavioural domains in adults with TBI. The search conducted across five databases yielded 1,019 results, of which 25 were relevant to this review. Meta-analyses were conducted where homogenous data was available.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Significant results favouring methylphenidate were recorded by meta-analyses for one of five cognition outcome measures (Trail Making Test A) (<jats:italic>p<\/jats:italic>\u202f=\u202f0.005, CI [\u22125.19, \u22120.91]), as well as the depression domain (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.00001, CI [\u22120.78, \u22120.39]) and the fatigue domain (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.00001, CI [\u22120.98, \u22120.67]). Insufficient data was available in the aggression, apathy, agitation, memory, motor function, post-concussion syndrome and sleep domains for inclusion in meta-analysis. Qualitative review of evidence in these domains found limited and mixed evidence on the efficacy of methylphenidate, though significant benefits have been demonstrated in these various domains in small, randomised studies. Eleven of the 25 studies were judged as containing some to high risk of bias. However, this review identified supportive evidence for the beneficial effects of methylphenidate to improve depression and fatigue in adults with TBI, with some possible benefits for cognition and other symptoms. Heterogeneity was high and risk of bias was variable across studies, somewhat limiting credibility of results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Methylphenidate may enhance the ongoing care of TBI patients, by addressing neurobehavioural and cognitive symptoms simultaneously. Further large-scale and high-quality clinical trials evaluating a comprehensive range of possible benefits to symptoms should be conducted to more conclusively elucidate the potential of methylphenidate for clinical efficacy in TBI.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1546080","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:15:43Z","timestamp":1741151743000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Methylphenidate for the cognitive and neurobehavioural sequelae of traumatic brain injury in adults: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Jemima L. C.","family":"Rees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl R.","family":"Krynicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Belli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2019","journal-title":"J Neurosurg"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psc.2013.11.004","article-title":"Cognitive sequelae of traumatic brain injury","volume":"37","author":"Rabinowitz","year":"2014","journal-title":"Psychiatr Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/01.HTR.0000314531.30401.39","article-title":"Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003","volume":"23","author":"Selassie","year":"2008","journal-title":"J Head Trauma Rehabil"},{"key":"ref4","volume-title":"Rehabilitation after traumatic injury. NICE guidelines NG211","year":"2022"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00228-019-02651-y","article-title":"Prevalence of medication and off-label medication use in acquired brain injury at a neurorehabilitation hospital","volume":"75","author":"Merino","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"ref6","article-title":"Methylphenidate hydrochloride","volume-title":"Joint formulary committee. British National Formulary","year":"2024"},{"key":"ref7","article-title":"Methylphenidate","volume-title":"StatPearls","author":"Verghese","year":"2023"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/02699058809150898","article-title":"Stimulant treatment for the neurobehavioral sequelae of traumatic brain injury","volume":"2","author":"Gualtieri","year":"1988","journal-title":"Brain Inj"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/01.phm.0000128789.75375.d3","article-title":"Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial","volume":"83","author":"Whyte","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e6960","DOI":"10.1097\/MD.0000000000006960","article-title":"Efficacy of methylphenidate for the treatment of mental sequelae after traumatic brain injury","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3109\/02699052.2015.1004747","article-title":"Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury","volume":"29","author":"Johansson","year":"2015","journal-title":"Brain Inj"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hup.668","article-title":"Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury","volume":"20","author":"Lee","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1080\/02699052.2018.1469166","article-title":"Methylphenidate-mediated motor control network enhancement in patients with traumatic brain injury","volume":"32","author":"Dorer","year":"2018","journal-title":"Brain Inj"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref15","unstructured":"Higgins\n              JPT\n            \n            \n              Thomas\n              J\n            \n            \n              Chandler\n              J\n            \n            \n              Cumpston\n              M\n            \n            \n              Li\n              T\n            \n            \n              Page\n              MJ\n            \n          \n          \n          2023"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/biomedicines12030643","article-title":"Neurotrauma \u2013 from injury to repair: clinical perspectives, cellular mechanisms and promoting regeneration of the injured brain and spinal cord","volume":"12","author":"Stevens","year":"2024","journal-title":"Biomed"},{"key":"ref17","volume-title":"Version 20.6","year":"2020"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/ijms15010309","article-title":"Traumatic brain injury pathophysiology and treatments: early, intermediate, and late phases post-injury","volume":"15","author":"Algattas","year":"2014","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/09602010802009201","article-title":"Rating the methodological quality of single-subject designs and n-of-1 trials: introducing the single-case experimental design scale","volume":"18","author":"Tate","year":"2007","journal-title":"Neuropsychol Rehabil"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref22","year":"2020"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"k4817","DOI":"10.1136\/bmj.k4817","article-title":"When continuous outcomes are measured using different scales: guide for meta-analysis and interpretation","volume":"364","author":"Murad","year":"2019","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/ane.12587","article-title":"Long-term treatment with methylphenidate for fatigue after traumatic brain injury","volume":"135","author":"Johansson","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/02699052.2019.1683898","article-title":"Follow-up after 5.5 years of treatment with methylphenidate for mental fatigue and cognitive function after a mild traumatic brain injury","volume":"34","author":"Johansson","year":"2020","journal-title":"Brain Inj"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3109\/02699052.2013.809553","article-title":"Effect of COMT Val158Met genotype on attention and response to methylphenidate following traumatic brain injury","volume":"27","author":"Willmott","year":"2013","journal-title":"Brain Inj"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12883-020-01663-x","article-title":"The effect of methylphenidate on attention in acquired brain injury as recorded by useful field of view","volume":"5","author":"Al-Adawi","year":"2005","journal-title":"J Appl Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.sleep.2005.11.008","article-title":"The effect of methylphenidate on the sleep-wake cycle of brain-injured patients undergoing rehabilitation","volume":"7","author":"Al-Adawi","year":"2006","journal-title":"Sleep Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/0269215516655590","article-title":"The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study","volume":"31","author":"Dymowski","year":"2017","journal-title":"Clin Rehabil"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1093\/brain\/awz149","article-title":"Stratifying drug treatment of cognitive impairments after traumatic brain injury using neuroimaging","volume":"142","author":"Jenkins","year":"2019","journal-title":"Brain"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3109\/02699052.2013.865267","article-title":"Evaluation of dosage, safety and effects of methylphenidate on post- traumatic brain injury symptoms with a focus on mental fatigue and pain","volume":"28","author":"Johansson","year":"2014","journal-title":"Brain Inj"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/s0003-9993(96)90211-7","article-title":"Methylphenidate effect on attention deficit in the acutely brain-injured adult","volume":"77","author":"Kaelin","year":"1996","journal-title":"Arch Phys Med Rehabil"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1191\/0269215506cr927oa","article-title":"Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study","volume":"20","author":"Kim","year":"2006","journal-title":"Clin Rehabil"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00213-011-2622-8","article-title":"Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: a perfusion fMRI study","volume":"222","author":"Kim","year":"2012","journal-title":"Psychopharmacology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fnbeh.2017.00058","article-title":"Working memory after traumatic brain injury: the neural basis of improved performance with methylphenidate","volume":"11","author":"Manktelow","year":"2017","journal-title":"Front Behav Neurosci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/npp.2015.282","article-title":"Randomized placebo-controlled trial of methylphenidate or Galantamine for persistent emotional and cognitive symptoms associated with PTSD and\/or traumatic brain injury","volume":"41","author":"McAllister","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/npp.2016.261","article-title":"Methylphenidate and memory and attention adaptation training for persistent cognitive symptoms after traumatic brain injury: a randomized, placebo-controlled trial","volume":"42","author":"McDonald","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5555\/uri:pii:000399939390355E","article-title":"Effect of methylphenidate on brain injury-related anger","volume":"74","author":"Mooney","year":"1993","journal-title":"Arch Phys Med Rehabil"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s11682-009-9072-5","article-title":"Effects of methylphenidate of working memory in traumatic brain injury: a preliminary fMRI investigation","volume":"3","author":"Newsome","year":"2009","journal-title":"Brain Imaging Behav"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/jcm13030771","article-title":"Methylphenidate ameliorates behavioural and neurobiological deficits in executive function for patients with chronic traumatic brain injury","volume":"13","author":"Peattie","year":"2024","journal-title":"J Clin Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/s0003-9993(96)90291-9","article-title":"Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study","volume":"77","author":"Plenger","year":"1996","journal-title":"Arch Phys Med Rehabil"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3109\/02699059309034959","article-title":"A double-blind controlled study of methylphenidate treatment in closed head injury","volume":"7","author":"Speech","year":"1993","journal-title":"Brain Inj"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1468-1331.1998.530297.x","article-title":"A randomized, double-blind, placebo-controlled study of methylphenidate in patients with organic amnesia","volume":"5","author":"Tiberti","year":"1998","journal-title":"Eur J Neurol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00002060-199711000-00002","article-title":"Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial","volume":"76","author":"Whyte","year":"1997","journal-title":"Am J Phys Med Rehabil"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/jnnp.2008.159632","article-title":"Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double-blind, placebo controlled inpatient trial","volume":"80","author":"Willmott","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hoojimans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/13607860412331336788","article-title":"The impact of speed processing training on cognitive and everyday performance","volume":"9","author":"Edwards","year":"2005","journal-title":"Aging Ment Health"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/23279095.2023.2225666","article-title":"A meta-analytic review examining the validity of executive functioning tests to predict functional outcomes in individuals with a traumatic brain injury","volume":"26","author":"Krynicki","year":"2023","journal-title":"Appl Neuropsychol Adult"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/1087054714543371","article-title":"Mild traumatic brain injury and ADHD: a systematic review of the literature and meta-analysis","volume":"18","author":"Adeyamo","year":"2014","journal-title":"J Atten Disord"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/cpt.3186","article-title":"Pharmacotherapy to improve cognitive functioning after acquired brain injury: a meta-analysis and meta-regression","volume":"115","author":"van der Veen","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/brainsci9110291","article-title":"Effects of methylphenidate on cognitive function in adults with traumatic brain injury: a meta-analysis","volume":"9","author":"Chien","year":"2019","journal-title":"Brain Sci"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2174\/1570159X13666150514233033","article-title":"Methylphenidate on cognitive improvement in patients with traumatic brain injury: a meta-analysis","volume":"14","author":"Huang","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1503\/jpn.190122","article-title":"Therapeutic benefits of pharmacologic and nonpharmacologic treatments for depressive symptoms after traumatic brain injury: a systematic review and network meta-analysis","volume":"46","author":"Cheng","year":"2021","journal-title":"J Psychiatry Neurosci"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1080\/02699052.2020.1797169","article-title":"The management of depression following traumatic brain injury: a systematic review with meta-analysis","volume":"34","author":"Beedham","year":"2020","journal-title":"Brain Inj"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.euroneuro.2016.12.002","article-title":"Anything goes? Regulation of neural processes underlying response inhibition in TBI patients","volume":"27","author":"Moreno-L\u00f3pez","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neurobiorev.2018.02.001","article-title":"The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities","volume":"87","author":"Faraone","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/WNF.0000000000000572","article-title":"The utility of methylphenidate for fatigue in long-term neurological conditions: a meta-analytical review","volume":"46","author":"Hagan","year":"2023","journal-title":"Clin Neuropharmacol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2340\/16501977-0369","article-title":"Safety of methylphenidate following traumatic brain injury: impact on vital signs and side effects during inpatient rehabilitation","volume":"41","author":"Willmott","year":"2009","journal-title":"J Rehabil Med"},{"key":"ref59","first-page":"86","article-title":"Methylphenidate and seizure frequency in brain injured patients with seizure disorders","volume":"53","author":"Wroblewski","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4088\/pcc.v02n0502","article-title":"Methylphenidate abuse and psychiatric side effects","volume":"2","author":"Morton","year":"2000","journal-title":"Prim Care Companion J Clin Psychiatry"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1546080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:15:49Z","timestamp":1741151749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1546080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":60,"alternative-id":["10.3389\/fneur.2025.1546080"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1546080","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"article-number":"1546080"}}